Last updated on March 2020

A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma


Brief description of study

Compare efficacy of 56 mg/m2 carfilzomib administered once-weekly in combination with lenalidomide and dexamethasone (KRd 56 mg/m2) to 27 mg/m2 carfilzomib administered twice-weekly in combination with lenalidomide and dexamethasone (KRd 27 mg/m2) in subjects with relapsed or refractory multiple myeloma (RRMM) with 1 to 3 prior lines of therapy.

Clinical Study Identifier: NCT03859427

Find a site near you

Start Over

Research Site

Fountain Valley, CA United States
  Connect »

Research Site

Plainville, CT United States
  Connect »

Research Site

Houston, TX United States
  Connect »

Research Site

Hradec Kralove, Czechia
  Connect »

Research Site

Thessaloniki, Greece
  Connect »

Research Site

Amsterdam, Netherlands
  Connect »

Research Site

Palma de Mallorca, Spain
  Connect »

Research Site

Pozuelo de Alarcon, Spain
  Connect »

Research Site

Moscow, Russian Federation
  Connect »

Research Site

Petrozavodsk, Russian Federation
  Connect »

Research Site

Poitiers Cedex, France
  Connect »

Research Site

Salamanca, Spain
  Connect »

Research Site

Bucharest, Romania
  Connect »

Research Site

Praha 2, Czechia
  Connect »

Research Site

Apeldoorn, Netherlands
  Connect »

Research Site

Timisoara, Romania
  Connect »

Research Site

Krasnoyarsk, Russian Federation
  Connect »

Research Site

Olomouc, Czechia
  Connect »

Research Site

Nice cedex 3, France
  Connect »

Research Site

Strasbourg cedex, France
  Connect »

Research Site

Toulouse cedex 9, France
  Connect »

Research Site

Vandoeuvre les Nancy, France
  Connect »

Research Site

Dresden, Germany
  Connect »

Research Site

Hamburg, Germany
  Connect »

Research Site

Kamogawa-shi, Japan
  Connect »

Research Site

Niigata-shi, Japan
  Connect »

Research Site

Goteborg, Sweden
  Connect »

Research Site

Halmstad, Sweden
  Connect »

Research Site

Istanbul, Turkey
  Connect »

Research Site

Jacksonville, FL United States
  Connect »

Research Site

Plovdiv, Bulgaria
  Connect »

Research Site

Pierre-Benite, France
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Nagoya-shi, Japan
  Connect »

Research Site

Toyohashi-shi, Japan
  Connect »

Research Site

Ogaki-shi, Japan
  Connect »

Research Site

Shibukawa-shi, Japan
  Connect »

Research Site

Kyoto-shi, Japan
  Connect »

Research Site

Okayama-shi, Japan
  Connect »

Research Site

Suita-shi, Japan
  Connect »

Research Site

Utsunomiya-shi, Japan
  Connect »

Research Site

Shibuya-ku, Japan
  Connect »

Research Site

Hoofddorp, Netherlands
  Connect »

Research Site

Bucuresti, Romania
  Connect »

Research Site

Cluj-Napoca, Romania
  Connect »

Research Site

Saint Petersburg, Russian Federation
  Connect »

Research Site

Samara, Russian Federation
  Connect »

Research Site

Barcelona, Spain
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Kawagoe-shi, Japan
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Alexandroupoli, Greece
  Connect »

Research Site

Fukuoka-shi, Japan
  Connect »

Research Site

Denton, TX United States
  Connect »

Research Site

Fort Worth, TX United States
  Connect »

Research Site

San Antonio, TX United States
  Connect »

Research Site

The Woodlands, TX United States
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Osakasayama-shi, Japan
  Connect »

Research Site

Albany, NY United States
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Denver, CO United States
  Connect »

Research Site

Cincinnati, OH United States
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »

Research Site

Vandoeuvre-lès-Nancy, France
  Connect »